Published in BMJ on February 22, 2011
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ (2014) 4.69
The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction (2012) 3.74
Do "Moderate" Drinkers Have Reduced Mortality Risk? A Systematic Review and Meta-Analysis of Alcohol Consumption and All-Cause Mortality. J Stud Alcohol Drugs (2016) 3.19
Prevalence of wine intolerance: results of a survey from Mainz, Germany. Dtsch Arztebl Int (2012) 2.67
Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal (2012) 1.96
Five year change in alcohol intake and risk of breast cancer and coronary heart disease among postmenopausal women: prospective cohort study. BMJ (2016) 1.74
Risk of myocardial infarction immediately after alcohol consumption. Epidemiology (2015) 1.43
Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients (2012) 1.33
Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol (2011) 1.21
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. Circulation (2016) 1.13
Framing international trade and chronic disease. Global Health (2011) 1.11
Heavy drinking occasions in relation to ischaemic heart disease mortality-- an 11-22 year follow-up of the 1984 and 1995 US National Alcohol Surveys. Int J Epidemiol (2011) 1.02
Publication bias in recent meta-analyses. PLoS One (2013) 1.00
Alcohol consumption, genetic variants in alcohol deydrogenases, and risk of cardiovascular diseases: a prospective study and meta-analysis. PLoS One (2012) 0.98
Alcoholism: a systemic proinflammatory condition. World J Gastroenterol (2014) 0.96
Multiple environmental chemical exposures to lead, mercury and polychlorinated biphenyls among childbearing-aged women (NHANES 1999-2004): Body burden and risk factors. Environ Res (2012) 0.96
Evidence of lifestyle modification in the management of hypercholesterolemia. Curr Cardiol Rev (2013) 0.96
Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation. J Am Coll Cardiol (2015) 0.95
Nutritional recommendations for cardiovascular disease prevention. Nutrients (2013) 0.94
Revisiting the cardiometabolic relevance of serum amylase. BMC Res Notes (2011) 0.91
Moderate alcohol use and cardiovascular disease from Mendelian randomization. PLoS One (2013) 0.89
Reality check: there is no such thing as a miracle food. Nutr Cancer (2013) 0.88
Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies. Eur J Epidemiol (2013) 0.88
The mechanism by which moderate alcohol consumption influences coronary heart disease. Nutr J (2015) 0.88
Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol (2015) 0.87
Protective Effects of the Mediterranean Diet on Type 2 Diabetes and Metabolic Syndrome. J Nutr (2016) 0.86
Metabolic and biochemical effects of low-to-moderate alcohol consumption. Alcohol Clin Exp Res (2012) 0.84
Association between the Mediterranean diet and cognitive decline in a biracial population. J Gerontol A Biol Sci Med Sci (2014) 0.84
Metabolic effects of a 13-weeks lifestyle intervention in older adults: The Growing Old Together Study. Aging (Albany NY) (2016) 0.83
Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic Steatosis. EBioMedicine (2016) 0.82
The Importance of Methodological Meta-Analyses and a Call to Assess Current and Former Drinking Patterns: A Commentary on Stockwell et al. (2016). J Stud Alcohol Drugs (2016) 0.82
Anthropometric, socioeconomic, and maternal health determinants of placental transfer of organochlorine compounds. Environ Sci Pollut Res Int (2013) 0.82
Alcohol and Immediate Risk of Cardiovascular Events: A Systematic Review and Dose-Response Meta-Analysis. Circulation (2016) 0.81
Black-White differences in the relationship between alcohol drinking patterns and mortality among US men and women. Am J Public Health (2015) 0.81
Food insecurity and dyslipidemia in a representative population-based sample in the US. Prev Med (2015) 0.81
Exploring causal associations of alcohol with cardiovascular and metabolic risk factors in a Chinese population using Mendelian randomization analysis. Sci Rep (2015) 0.81
Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart (2014) 0.81
Alcohol Use and Gamma-Glutamyltransferase Using a Mendelian Randomization Design in the Guangzhou Biobank Cohort Study. PLoS One (2015) 0.81
Alcohol abstention in early adulthood and premature mortality: Do early life factors, social support, and health explain this association? Soc Sci Med (2016) 0.81
Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11. BMC Public Health (2016) 0.81
Alcohol consumption patterns, beverage type, and long-term mortality among women survivors of acute myocardial infarction. Am J Cardiol (2011) 0.80
Cardiorespiratory fitness, alcohol intake, and metabolic syndrome incidence in men. Med Sci Sports Exerc (2012) 0.80
Long-term change in alcohol-consumption status and variations in fibrinogen levels: the coronary artery risk development in young adults (CARDIA) study. BMJ Open (2013) 0.80
Depressive symptoms and serum lipid levels in young adult women. J Behav Med (2012) 0.80
Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity. Nutr J (2015) 0.80
Measuring the burden--current and future research trends: results from the NIAAA Expert Panel on Alcohol and Chronic Disease Epidemiology. Alcohol Res (2013) 0.80
Effects of acute exercise on liver function and blood redox status in heavy drinkers. Exp Ther Med (2015) 0.80
Mediterranean Alcohol-Drinking Pattern and the Incidence of Cardiovascular Disease and Cardiovascular Mortality: The SUN Project. Nutrients (2015) 0.80
Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study. PLoS One (2016) 0.79
Alcohol and incident heart failure among middle-aged and elderly men: cohort of Swedish men. Circ Heart Fail (2015) 0.79
Higher self-reported prevalence of hypertension among Moluccan-Dutch than among the general population of The Netherlands: results from a cross-sectional survey. BMC Public Health (2014) 0.78
Women's health in the Lund area (WHILA) - Alcohol consumption and all-cause mortality among women - a 17 year follow-up study. BMC Public Health (2016) 0.78
Omega-3 index and smoking in patients with acute ST-elevation myocardial infarction taking statins: a case-control study in Korea. Lipids Health Dis (2012) 0.78
Modelling the impact of alcohol consumption on cardiovascular disease mortality for comparative risk assessments: an overview. BMC Public Health (2016) 0.78
Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice. Eur J Nutr (2015) 0.78
Metabolic profiling of alcohol consumption in 9778 young adults. Int J Epidemiol (2016) 0.78
The Association between Alcohol Consumption and β-Cell Function and Insulin Sensitivity in Korean Population. Int J Environ Res Public Health (2016) 0.77
Longitudinal study of alcohol consumption and HDL concentrations: a community-based study. Am J Clin Nutr (2017) 0.77
The Role of Alcohol Consumption in Regulating Circulating Levels of Adiponectin: A Prospective Cohort Study. J Clin Endocrinol Metab (2015) 0.77
Magnitude of cardiovascular risk factors in rural and urban areas in Benin: findings from a nationwide steps survey. PLoS One (2015) 0.77
Presence of fatty liver and the relationship between alcohol consumption and markers of inflammation. Mediators Inflamm (2015) 0.77
Depression inhibits the anti-inflammatory effects of leisure time physical activity and light to moderate alcohol consumption. Brain Behav Immun (2013) 0.77
Drinking problems and mortality risk in the United States. Drug Alcohol Depend (2015) 0.77
Alcohol Dehydrogenase-1B (rs1229984) and Aldehyde Dehydrogenase-2 (rs671) Genotypes Are Strong Determinants of the Serum Triglyceride and Cholesterol Levels of Japanese Alcoholic Men. PLoS One (2015) 0.76
Alcohol: taking a population perspective. Nat Rev Gastroenterol Hepatol (2016) 0.76
The effect of moderate alcohol consumption on biomarkers of inflammation and hemostatic factors in postmenopausal women. Eur J Clin Nutr (2015) 0.76
Alcohol Consumption and Metabolic Syndrome Among Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos. Metab Syndr Relat Disord (2016) 0.76
Moderate wine consumption is associated with lower hemostatic and inflammatory risk factors over 8 years: The study of women's health across the nation (SWAN). Nutr Aging (Amst) (2014) 0.76
Relationship between Alcohol Consumption and Components of the Metabolic Syndrome in Adult Population from Maracaibo City, Venezuela. Adv Prev Med (2015) 0.76
Are psychosocial stressors associated with the relationship of alcohol consumption and all-cause mortality? BMC Public Health (2014) 0.76
Alcohol consumption over time and mortality in the Swedish Women's Lifestyle and Health cohort. BMJ Open (2016) 0.76
Epigenetic clock analysis of diet, exercise, education, and lifestyle factors. Aging (Albany NY) (2017) 0.76
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events. J Acquir Immune Defic Syndr (2016) 0.76
Moderate Alcohol Consumption and Chronic Disease: The Case for a Long-Term Trial. Alcohol Clin Exp Res (2016) 0.75
Ten-year alcohol consumption typologies and trajectories of C-reactive protein, interleukin-6 and interleukin-1 receptor antagonist over the following 12 years: a prospective cohort study. J Intern Med (2016) 0.75
'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2012) 0.75
Beverage Intake and Metabolic Syndrome Risk Over 14 Years: The Study of Women's Health Across the Nation. J Acad Nutr Diet (2016) 0.75
Cross-Sectional Associations between Empirically-Derived Dietary Patterns and Indicators of Disease Risk among University Students. Nutrients (2015) 0.75
Coronary artery plaque burden and calcium scores in healthy men adhering to long-term wine drinking or alcohol abstinence. Braz J Med Biol Res (2014) 0.75
Twenty-year trajectories of alcohol consumption during midlife and atherosclerotic thickening in early old age: findings from two British population cohort studies. BMC Med (2016) 0.75
Hepatic, lipid and genetic factors associated with obesity: crosstalk with alcohol dependence? World J Biol Psychiatry (2016) 0.75
Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study. Clin Chem (2016) 0.75
Acute alcohol consumption elevates serum bilirubin: an endogenous antioxidant. Drug Alcohol Depend (2015) 0.75
Altered Transport and Metabolism of Phenolic Compounds in Obesity and Diabetes: Implications for Functional Food Development and Assessment. Adv Nutr (2016) 0.75
Dietary intake and peripheral arterial disease incidence in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2017) 0.75
Key Findings on Alcohol Consumption and a Variety of Health Outcomes From the Nurses' Health Study. Am J Public Health (2016) 0.75
Diurnal triglyceridemia in relation to alcohol intake in men. Nutrients (2013) 0.75
Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med (2016) 0.75
The Protective Effect of Low-Dose Ethanol on Myocardial Fibrosis through Downregulating the JNK Signaling Pathway in Diabetic Rats. J Diabetes Res (2016) 0.75
Myocardial infarction in the Wisconsin Longitudinal Study: the interaction among environmental, health, social, behavioural and genetic factors. BMJ Open (2017) 0.75
Relationship Between Alcohol Drinking Pattern and Risk of Proteinuria: The Kansai Healthcare Study. J Epidemiol (2016) 0.75
Markers of inflammation and mortality in a cohort of patients with alcohol dependence. Medicine (Baltimore) (2015) 0.75
Assessing alcohol intake & its dose-dependent effects on liver enzymes by 24-h recall and questionnaire using NHANES 2001-2010 data. Nutr J (2016) 0.75
Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview. J Nutr Metab (2017) 0.75
Designing Dietary Recommendations Using System Level Interactomics Analysis and Network-Based Inference. Front Physiol (2017) 0.75
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Inflammation in atherosclerosis. Nature (2002) 28.92
Adipose tissue, inflammation, and cardiovascular disease. Circ Res (2005) 8.72
Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ (1999) 4.14
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med (2005) 2.88
Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care (2004) 2.24
Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med (2008) 2.01
How much alcohol is in a 'standard drink'? An analysis of 125 studies. Br J Addict (1990) 1.50
Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipids. Metabolism (1987) 1.44
Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids (2005) 1.38
Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr (2002) 1.27
Alterations of lipid metabolism in healthy volunteers during long-term ethanol intake. Eur J Clin Invest (1977) 1.26
Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet (1983) 1.26
Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation (2000) 1.25
Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis (2004) 1.19
Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation (2001) 1.18
Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmenopausal women: a randomised, crossover trial. Diabetologia (2008) 1.18
Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta (1996) 1.15
Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men. Atherosclerosis (1999) 1.12
Alcohol-induced changes in serum lipoproteins and in their metabolism. Am Heart J (1987) 1.10
Moderate alcohol consumption lowers risk factors for cardiovascular disease in postmenopausal women fed a controlled diet. Am J Clin Nutr (2002) 1.07
The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: a human intervention study. Diabetologia (2007) 1.07
Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. Eur J Clin Nutr (2007) 1.02
Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Eur J Clin Nutr (2005) 1.01
Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers. Alcohol Clin Exp Res (2002) 1.00
The effect of moderate alcohol consumption on fat distribution and adipocytokines. Obesity (Silver Spring) (2006) 1.00
The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes Obes Metab (2007) 0.99
Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men. Metabolism (1990) 0.99
Health risks and benefits of alcohol consumption. Alcohol Res Health (2000) 0.98
Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. Acta Med Scand Suppl (1973) 0.96
The effect of alcohol on serum high density lipoprotein (HDL). A controlled experiment. Atherosclerosis (1983) 0.95
Effects of alcohol on plasma lipoproteins and cholesterol and triglyceride metabolism in man. J Lipid Res (1984) 0.93
Effect of drinking on adiponectin in healthy men and women: a randomized intervention study of water, ethanol, red wine, and beer with or without alcohol. Diabetes Care (2009) 0.93
Alcohol and high-density-lipoprotein cholesterol: a randomized controlled trial. Br J Nutr (1986) 0.91
Short-term effects of moderate alcohol consumption on lipid metabolism and energy balance in normal men. Metabolism (1989) 0.91
Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men. JAMA (1983) 0.91
Effects of alcohol consumption on lipoproteins of premenopausal women. A controlled diet study. Arterioscler Thromb Vasc Biol (1995) 0.91
Metabolic effects of alcohol in the form of wine in persons with type 2 diabetes mellitus. Metabolism (2008) 0.90
Relationship between serum leptin levels and alcohol consumption in a controlled feeding and alcohol ingestion study. J Natl Cancer Inst (2003) 0.90
The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers. Br J Nutr (2005) 0.90
The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Atherosclerosis (2005) 0.89
A daily glass of red wine induces a prolonged reduction in plasma viscosity: a randomized controlled trial. Blood Coagul Fibrinolysis (2006) 0.88
Effects of moderate alcohol intake in fixed or variable amounts on concentration of serum lipids and liver enzymes in healthy young men. Am J Clin Nutr (1989) 0.88
Alcohol consumption stimulates early steps in reverse cholesterol transport. J Lipid Res (2001) 0.87
Effect of red wine consumption on lipoprotein (a) and other risk factors for atherosclerosis. QJM (1995) 0.87
Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII. Eur J Clin Invest (1999) 0.86
Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors. Eur J Clin Nutr (2001) 0.85
Effects of moderate beer consumption on first-line immunity of healthy adults. J Physiol Biochem (2007) 0.85
Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J Nutr (2007) 0.85
Changes in the immune system after moderate beer consumption. Ann Nutr Metab (2007) 0.84
Effect of a moderate alcohol intake on the lipoproteins of normotriglyceridemic obese subjects compared with normoponderal controls. Metabolism (1992) 0.84
The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a). Metabolism (1991) 0.83
The effect of red wine on plasma leptin levels and vasoactive factors from adipose tissue: a randomized crossover trial. Alcohol Alcohol (2007) 0.83
A daily glass of red wine: does it affect markers of inflammation? Alcohol Alcohol (2005) 0.83
Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation. Atherosclerosis (1994) 0.83
Moderate alcohol consumption and lipoprotein-associated phospholipase A2 activity. Nutr Metab Cardiovasc Dis (2007) 0.82
Effects of alcohol ingestion on lipids and lipoproteins in normal men: isocaloric metabolic studies. Am J Clin Nutr (1980) 0.82
Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women. Am J Cardiol (1986) 0.82
Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long-term uptake of ethanol in healthy subjects. Atherosclerosis (1985) 0.81
Red-wine beneficial long-term effect on lipids but not on antioxidant characteristics in plasma in a study comparing three types of wine--description of two O-methylated derivatives of gallic acid in humans. Free Radic Res (2003) 0.81
Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers. Clin Chim Acta (1985) 0.81
Daily moderate amounts of red wine or alcohol have no effect on the immune system of healthy men. Eur J Clin Nutr (2004) 0.80
Effect of moderate alcohol consumption on fibrinogen levels in healthy volunteers is discordant with effects on C-reactive protein. Ann N Y Acad Sci (2001) 0.80
Effect of moderate alcohol consumption on parameters of reverse cholesterol transport in postmenopausal women. Alcohol Clin Exp Res (2004) 0.80
Effects of alcohol consumption on antioxidant content and susceptibility of low-density lipoprotein to oxidative modification. J Am Coll Nutr (1994) 0.79
Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk. Am J Cardiol (1997) 0.79
Plasma circulating fibrinogen stability and moderate beer consumption. J Nutr Biochem (2003) 0.78
Comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteins A-I and A-II: a controlled study. Eur J Clin Invest (1988) 0.78
Mediterranean diet, but not red wine, is associated with beneficial changes in primary haemostasis. Eur J Clin Nutr (2003) 0.78
Regular alcohol intake and fibrinolysis. Neth J Med (2002) 0.78
Beneficial effects of a moderate consumption of red wine on cellular cholesterol efflux in young men. Nutr Metab Cardiovasc Dis (2000) 0.78
Time-course, magnitude and nature of the changes induced in HDL by moderate alcohol intake in young non-drinking males. Atherosclerosis (1986) 0.77
High density lipoprotein cholesterol and apoprotein A1 in healthy volunteers during long-term moderate alcohol intake. Ann Nutr Metab (1984) 0.77
Wine: does the colour count? Clin Chim Acta (1996) 0.77
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care (2005) 30.41
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ (2004) 21.24
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09
Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2007) 7.79
Association of weight status with mortality in adults with incident diabetes. JAMA (2012) 7.49
New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol (2004) 7.20
D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med (2004) 6.15
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care (2002) 5.92
Physician wellness: a missing quality indicator. Lancet (2009) 5.50
Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care (2004) 5.12
Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med (2006) 4.90
Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res (2008) 4.25
Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care (2004) 4.15
The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials (2002) 3.62
Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis (2003) 3.60
History of kidney stones and the risk of coronary heart disease. JAMA (2013) 3.23
Survival after coronary revascularization in the elderly. Circulation (2002) 3.17
Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med (2010) 3.17
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06
Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med (2007) 3.06
Dealing with missing data in a multi-question depression scale: a comparison of imputation methods. BMC Med Res Methodol (2006) 2.81
Should the hemoglobin A1c diagnostic cutoff differ between blacks and whites? A cross-sectional study. Ann Intern Med (2012) 2.75
Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74
Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med (2009) 2.72
Chronic noncancer pain management and opioid overdose: time to change prescribing practices. Ann Intern Med (2010) 2.70
Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol (2005) 2.69
Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med (2004) 2.64
An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol (2004) 2.58
Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke (2005) 2.50
Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc (2010) 2.42
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32
Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol (2002) 2.30
Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation (2012) 2.30
Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med (2007) 2.30
Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30
Healthcare and lifestyle practices of healthcare workers: do healthcare workers practice what they preach? JAMA Intern Med (2013) 2.29
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol (2012) 2.22
Effectiveness of interventions targeting frequent users of emergency departments: a systematic review. Ann Emerg Med (2011) 2.19
Development of a frailty index for patients with coronary artery disease. J Am Geriatr Soc (2010) 2.18
Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int (2013) 2.17
Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care (2007) 2.14
Outcomes after aortic and mitral valve replacement surgery in Canada: 1994/95 to 1999/2000. Can J Cardiol (2004) 2.11
Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg (2007) 2.06
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05
The characteristics and impact of a hospitalist-staffed post-discharge clinic. Am J Med (2013) 2.04
Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension (2013) 2.03
Alcohol and long-term prognosis after a first acute myocardial infarction: the SHEEP study. Eur Heart J (2007) 2.02
Overview of a formal scoping review on health system report cards. Implement Sci (2010) 1.95
Access to health care among status Aboriginal people with chronic kidney disease. CMAJ (2008) 1.91
Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 1.88
Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med (2010) 1.88
Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin. J Am Coll Cardiol (2013) 1.85
Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 1.85
Prospective study of alcohol drinking patterns and coronary heart disease in women and men. BMJ (2006) 1.81
Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res (2006) 1.80
Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time. JAMA (2004) 1.79
Plasma omega-3 fatty acids and incident diabetes in older adults. Am J Clin Nutr (2011) 1.79
Measuring quality of care in patients with multiple clinical conditions: summary of a conference conducted by the Society of General Internal Medicine. J Gen Intern Med (2007) 1.77
Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med (2008) 1.76
Association between adiposity in midlife and older age and risk of diabetes in older adults. JAMA (2010) 1.72
Development and validation of a surname list to define Chinese ethnicity. Med Care (2006) 1.71
Sodium excretion and risk of developing coronary heart disease. Circulation (2014) 1.67
Quality of life after coronary revascularization in the elderly. Eur Heart J (2006) 1.66
Multiple imputation versus data enhancement for dealing with missing data in observational health care outcome analyses. J Clin Epidemiol (2002) 1.65
Variation in health services utilization among ethnic populations. CMAJ (2006) 1.64
Population rates of cardiac catheterization and yield of high-risk coronary artery disease. CMAJ (2005) 1.64
n-3 fatty acids and periodontitis in US adults. J Am Diet Assoc (2010) 1.64
Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data. J Clin Epidemiol (2004) 1.62
Light-to-moderate alcohol consumption and risk of sudden cardiac death in women. Heart Rhythm (2010) 1.61
Racial disparities in hypertension control, but not treatment intensification. Am J Hypertens (2009) 1.59
Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol (2006) 1.58
Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med (2013) 1.57
The Enhancing Secondary Prevention in Coronary Artery Disease trial. CMAJ (2009) 1.57
Suicide among US veterans: A prospective study of 500,000 middle-aged and elderly men. Am J Epidemiol (2009) 1.56
Alcohol in moderation, cardioprotection, and neuroprotection: epidemiological considerations and mechanistic studies. Alcohol Clin Exp Res (2008) 1.55
Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 1.55
Urinary and plasma magnesium and risk of ischemic heart disease. Am J Clin Nutr (2013) 1.54
Women with coronary artery disease report worse health-related quality of life outcomes compared to men. Health Qual Life Outcomes (2004) 1.53
Accuracy of city postal code coordinates as a proxy for location of residence. Int J Health Geogr (2004) 1.52
Venous thromboembolic disease: comparison of the diagnostic process in blacks and whites. Arch Intern Med (2003) 1.51
Public versus private institutional performance reporting: what is mandatory for quality improvement? Am Heart J (2006) 1.50
Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int (2010) 1.50
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm (2011) 1.48
Relation of T-axis abnormalities to coronary artery disease and survival after cardiac catheterization. Am J Cardiol (2005) 1.48
Exploring the treatment-risk paradox in coronary disease. Arch Intern Med (2007) 1.48
Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol (2007) 1.47
Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study. BMJ (2013) 1.46
In the dark: the reporting of blinding status in randomized controlled trials. J Clin Epidemiol (2002) 1.45
Rapid evaluation after high-risk TIA is associated with lower stroke risk. Can J Neurol Sci (2009) 1.45
Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon? Int J Cardiol (2007) 1.45
Plasma free fatty acids and risk of stroke in the Cardiovascular Health Study. Int J Stroke (2014) 1.45
Identifying priorities in methodological research using ICD-9-CM and ICD-10 administrative data: report from an international consortium. BMC Health Serv Res (2006) 1.45
Counselling overweight and obese patients in primary care: a prospective cohort study. Eur J Cardiovasc Prev Rehabil (2006) 1.44
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44
Risk of myocardial infarction immediately after alcohol consumption. Epidemiology (2015) 1.43